Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Investigating AMD retinal biomarkers in a rat model of CNV
Author Affiliations & Notes
  • Teresa Mammone
    Health Science & Medicine, Bond University Ltd, Robina, Queensland, Australia
    Clem Jones Group, East Brisbane, Queensland, Australia
  • Helen O'Neill
    Health Science & Medicine, Bond University Ltd, Robina, Queensland, Australia
    Clem Jones Group, East Brisbane, Queensland, Australia
  • Nigel Barnett
    Health Science & Medicine, Bond University Ltd, Robina, Queensland, Australia
    Clem Jones Group, East Brisbane, Queensland, Australia
  • Footnotes
    Commercial Relationships   Teresa Mammone None; Helen O'Neill None; Nigel Barnett None
  • Footnotes
    Support  NHMRC Grant APP1186742
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 4975. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Teresa Mammone, Helen O'Neill, Nigel Barnett; Investigating AMD retinal biomarkers in a rat model of CNV. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4975.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinal biomarkers are of increasing importance in identifying preclinical, clinical and advanced disease progression. In the multifactorial eye disease, age-related macular degeneration (AMD), of which there are two types, wet-AMD is the consequence of choroidal neovascularisation (CNV). The effect of CNV leads to lipid and blood exudation into the retina resulting in tissue damage and the infiltration of inflammatory mediators. The infiltration and proliferation of glial cells, macrophages in addition to secreted cytokines results in excess wound healing, fibrovascular scaring and consequently deterioration of vision. This study will investigate retinal function and pathology associated with CNV formation to identify new retinal biomarkers, and in doing so, could provide vital information in sight preservation.

Methods : A CNV-laser model was established with female Brown-Norway rats. CNV lesions were induced in one eye of each animal with a 532 nM laser. A longitudinal investigation of 28 days examined retinal function and pathology. Retinal function was investigated with full-field electroretinography (ERG; n=6-12) by analysis of a-wave, b-wave and Oscillatory Potentials (OPs). In vivo imaging was studied by optical coherence tomography (OCT: n=50) and fundus imaging. Hyper-reflective foci (HRF) were further identified and established as retinal biomarkers. Eyes were enucleated and processed for histopathological analysis (n=3-7). A mixed effect model and ANOVA were used for statistical analysis.

Results : ERG showed reduced retinal function of a-, b-wave and OPs in laser treated eyes. Fundus and OCT examination revealed in vivo retinal biomarkers and HRF. Histological analysis of isolectin-B4, glial activation and infiltration of inflammatory mediators were identified and consistent with changes associated with laser treatment.

Conclusions : These results suggest that OPs are a more sensitive marker of retinal function and showed progressive decline subsequent to a- and b-wave stabilisation in CNV-laser model. OCT imaging confirmed specific characteristics of CNV changes. However, OCT is limited in its ability to identify the origins of retinal biomarkers. Together with histopathological analysis, retinal biomarker origins could provide vital information for targeted therapeutic intervention in mitigating disease progression.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×